Comparing the Radial Extracorporeal Shock Waves and Botulinum Toxin Injection for Spasticity

Post-Stroke Upper Limb Spasticity Clinical Trial

Official title: Radial Extracorporeal Shock Wave Versus Botulinum Toxin A in the Treatment of Post-Stroke Upper Limb Spasticity: A Randomized Non-Inferiority Trial

Status Completed

Clinical Trial Summary

Botulinum toxin type A (BoNT-A) is widely used in the clinics to reduce spasticity and improve upper limb function for post-stroke patients. However, there were no studies to compare the effect of rESWT and BoNT-A injection for treatment on spasticity.

Clinical Trial Description

Botulinum toxin type A (BoNT-A) is widely used in the clinics to reduce spasticity and improve upper limb function for post-stroke patients. However, the treatments of BoNT-A injection are associated with high cost and invasive treatment. Recent studies have showed that radial extracorporeal shock wave (rESWT) is a novel, effective and safety treatment method for the spasticity. However, there were no studies to compare the effect of rESWT and BoNT-A injection for treatment on spasticity. ;

Related Conditions & MeSH terms

• Muscle Spasticity
• Post-Stroke Upper Limb Spasticity
• Stroke

• NCT number: NCT03131791
• Study type: Interventional
• Source: Mackay Memorial Hospital
• Status: Completed
• Phase: N/A
• Start date: April 1, 2017
• Completion date: September 30, 2017